ArQule, Inc. (NASDAQ:ARQL)

Foot_Locker_store

Four Unusual Stock Winners on a Down Friday

Are you panicking about a government shutdown or about no debt ceiling deal yet? Apparently that is all the market can think of as Washington, D.C., is yet again holding ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — January 11, 2013: Markets Open Mixed, Tick Higher by Close (JCP, GIS, AIG, RIMM, VIAB, SNX, WFC, PPG, NOK, BBY, UPIP, ARQL)

U.S. equity markets opened slightly lower this morning as data from Europe and Asia combined with a larger than expected U.S. trade deficit to pour cool, if not cold, water ...
Read Full Story »
biotech

ArQule Fails in Colorectal Cancer Trials

ArQule Inc. (NASDAQ: ARQL) is about to lose some serious hope for investors. It and Daiichi Sankyo announced that the top-line results of phase 2 trial with tivantinib in colorectal cancer did not meet ...
Read Full Story »

24/7 Wall St. Closing Bell — October 2, 2012: Markets Stagnate as Stocks Slide (KBH, WFC, KCG, C, SIRI, TISI, AYI, MOS, FDO, MON, RPM, PCS, ARQL, EXPR, PBM)

The three major U.S. stock indexes opened higher this morning but have had trouble staying above the neutral line since late morning. Early reports that Spain would soon ask for ...
Read Full Story »

Today’s Market Winners and Losers

The stock market is mixed on Tuesday, with the Dow Jones Industrial Average down 0.01%, the Nasdaq up 0.21% and the S&P up 0.51%. Tuesday's winners include a telecommunications company ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Today's edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend.  There ...
Read Full Story »

Top Day Trader Alerts (ARQL, BPAX, BMY, BP, CTIC, KRY, TLCR, VVUS)

We have several big movers on news this morning, and none appear to be based upon earnings.  Stocks on the move are ArQule Inc. (NASDAQ: ARQL), BioSante Pharmaceuticals, Inc. (NASDAQ: ...
Read Full Story »

BioHealth Business Daily (AEN, ARQL, CTIC, ENCO, GENZ, OMER, OXGN, VVUS)

Today's version of the BioHealth Business Daily seems to be more influenced by outside factors more than big blockbuster news.  Still we have many movers, some on news.  Today's cast ...
Read Full Story »

Top Analyst Downgrades (ARQL, ASML, CSCO, MEDX, MSFT)

These are the top analyst downgrades and cautious research calls we have seen from Wall Street this Thursday morning: ArQule (ARQL) Cut to Sell at UBS. ASML (ASML) Cut to ...
Read Full Story »

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down ...
Read Full Story »

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year's American Society of Clinical Oncology meeting for 2009.  At BioHealthInvestor.com we compiled ...
Read Full Story »